OrbiMed Capital GP V LLC, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), sold 2,219,288 shares at $6.09 ($13.5M) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Open-market sale of $13.5M CRVS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.09 | 1,109,644 | $6.8M | 50.0% |
| 2 | $6.09 | 1,109,644 | $6.8M | 50.0% |
| Total | $6.09 avg | 2,219,288 | $13.5M | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |
| INSP | SELL | 2020-08-19 | $19.7M | — | Filing → |